Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-03-098047
Filing Date
2003-12-22
Accepted
2003-12-22 14:41:19
Documents
10
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 924485
3 LICENSE AGREEMENT DATED AUGUST 22, 2003 dex10133.htm EX-10.133 218744
4 ASSIGNMENT AND TERMINATION AGREEMENT DATED AUGUST 22, 2003 dex10134.htm EX-10.134 92517
5 FISCAL YEAR 2004 SENIOR EXECUTIVE BONUS PLAN dex10135.htm EX-10.135 23922
6 LIST OF SUBSIDIARIES dex21.htm EX-21 2179
7 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex23.htm EX-23 2124
8 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 9221
9 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 9225
10 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER U.S.C. 18 SEC 1350 dex321.htm EX-32.1 2679
11 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER U.S.C. 18 SEC 1350 dex322.htm EX-32.2 2683
  Complete submission text file 0001193125-03-098047.txt   1290718
Mailing Address ONE LEDGEMONT CENTER 99 HAYDEN AVE LEXINGTON MA 02421
Business Address ONE LEDGEMONT CENTER 99 HAYDEN AVE LEXINGTON MA 02421 6178618444
INDEVUS PHARMACEUTICALS INC (Filer) CIK: 0000854222 (see all company filings)

EIN.: 043047911 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-18728 | Film No.: 031067411
SIC: 2834 Pharmaceutical Preparations